Immunisation issues for Indigenous Australian children

Robert Menzies, Ross Andrews

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    Vaccination has provided major benefits to the health of indigenous children in the face of continuing poorer socioe-conomic conditions but several issues have been identified for improvement. While indigenous children are vaccinated at high rates for the standard schedule vaccines, vaccination is more commonly delayed. Coverage for 'targeted' vaccines is substantially lower, and data on coverage for indigenous adolescents is non-existent. Improved identification of indigenous clients by immunisation providers and the expansion of the childhood register are required. The progressive removal of early-acting Haemophilus influenzae type b vaccines from schedules for indigenous children because of an international shortage raises the risk of disease re-emergence and highlights the need for vigilant surveillance including carriage. The expanded use of existing vaccines (influenza) and early adoption of new vaccines (higher valency pneumococcal conjugates) are needed to maximise benefits, in particular the potential to impact on non-invasive disease such as otitis media and non-bacteraemic pneumonia that are so prevalent in indigenous children.
    Original languageEnglish
    Pages (from-to)E21-E25
    Number of pages5
    JournalJournal of Paediatrics and Child Health
    Volume50
    Issue number10
    DOIs
    Publication statusPublished - Oct 2014

    Fingerprint

    Immunization
    Vaccines
    Appointments and Schedules
    Haemophilus Vaccines
    Vaccination
    Haemophilus influenzae type b
    Influenza Vaccines
    Otitis Media
    Insurance Benefits
    Pneumonia
    Child Health

    Cite this

    @article{a08b000b042e43558f2dc6757b867ff0,
    title = "Immunisation issues for Indigenous Australian children",
    abstract = "Vaccination has provided major benefits to the health of indigenous children in the face of continuing poorer socioe-conomic conditions but several issues have been identified for improvement. While indigenous children are vaccinated at high rates for the standard schedule vaccines, vaccination is more commonly delayed. Coverage for 'targeted' vaccines is substantially lower, and data on coverage for indigenous adolescents is non-existent. Improved identification of indigenous clients by immunisation providers and the expansion of the childhood register are required. The progressive removal of early-acting Haemophilus influenzae type b vaccines from schedules for indigenous children because of an international shortage raises the risk of disease re-emergence and highlights the need for vigilant surveillance including carriage. The expanded use of existing vaccines (influenza) and early adoption of new vaccines (higher valency pneumococcal conjugates) are needed to maximise benefits, in particular the potential to impact on non-invasive disease such as otitis media and non-bacteraemic pneumonia that are so prevalent in indigenous children.",
    keywords = "cancer vaccine, Haemophilus influenzae type b vaccine, influenza vaccine, Pneumococcus vaccine, Haemophilus influenzae type b polysaccharide vaccine, Haemophilus vaccine, hepatitis A vaccine, child, Haemophilus influenzae, health care access, health promotion, hepatitis A, human, immunization, Indigenous Australian, infection prevention, influenza, otitis media, pneumococcal infection, pneumonia, register, Review, Rotavirus, uterine cervix cancer, vaccination, adolescent, Australia, bacterial capsule, child welfare, female, indigenous health care, infection control, male, needs assessment, organization and management, preschool child, preventive health service, procedures, risk assessment, standards, statistics and numerical data, trends, Adolescent, Bacterial Capsules, Child, Child Welfare, Child, Preschool, Communicable Disease Control, Female, Haemophilus Vaccines, Health Services, Indigenous, Hepatitis A Vaccines, Humans, Immunization, Immunization Programs, Male, Needs Assessment, Pneumococcal Vaccines, Risk Assessment, Vaccination",
    author = "Robert Menzies and Ross Andrews",
    year = "2014",
    month = "10",
    doi = "10.1111/j.1440-1754.2011.02079.x",
    language = "English",
    volume = "50",
    pages = "E21--E25",
    journal = "Journal of Paediatrics and Child Health",
    issn = "1034-4810",
    publisher = "Wiley-Blackwell",
    number = "10",

    }

    Immunisation issues for Indigenous Australian children. / Menzies, Robert; Andrews, Ross.

    In: Journal of Paediatrics and Child Health, Vol. 50, No. 10, 10.2014, p. E21-E25.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Immunisation issues for Indigenous Australian children

    AU - Menzies, Robert

    AU - Andrews, Ross

    PY - 2014/10

    Y1 - 2014/10

    N2 - Vaccination has provided major benefits to the health of indigenous children in the face of continuing poorer socioe-conomic conditions but several issues have been identified for improvement. While indigenous children are vaccinated at high rates for the standard schedule vaccines, vaccination is more commonly delayed. Coverage for 'targeted' vaccines is substantially lower, and data on coverage for indigenous adolescents is non-existent. Improved identification of indigenous clients by immunisation providers and the expansion of the childhood register are required. The progressive removal of early-acting Haemophilus influenzae type b vaccines from schedules for indigenous children because of an international shortage raises the risk of disease re-emergence and highlights the need for vigilant surveillance including carriage. The expanded use of existing vaccines (influenza) and early adoption of new vaccines (higher valency pneumococcal conjugates) are needed to maximise benefits, in particular the potential to impact on non-invasive disease such as otitis media and non-bacteraemic pneumonia that are so prevalent in indigenous children.

    AB - Vaccination has provided major benefits to the health of indigenous children in the face of continuing poorer socioe-conomic conditions but several issues have been identified for improvement. While indigenous children are vaccinated at high rates for the standard schedule vaccines, vaccination is more commonly delayed. Coverage for 'targeted' vaccines is substantially lower, and data on coverage for indigenous adolescents is non-existent. Improved identification of indigenous clients by immunisation providers and the expansion of the childhood register are required. The progressive removal of early-acting Haemophilus influenzae type b vaccines from schedules for indigenous children because of an international shortage raises the risk of disease re-emergence and highlights the need for vigilant surveillance including carriage. The expanded use of existing vaccines (influenza) and early adoption of new vaccines (higher valency pneumococcal conjugates) are needed to maximise benefits, in particular the potential to impact on non-invasive disease such as otitis media and non-bacteraemic pneumonia that are so prevalent in indigenous children.

    KW - cancer vaccine

    KW - Haemophilus influenzae type b vaccine

    KW - influenza vaccine

    KW - Pneumococcus vaccine

    KW - Haemophilus influenzae type b polysaccharide vaccine

    KW - Haemophilus vaccine

    KW - hepatitis A vaccine

    KW - child

    KW - Haemophilus influenzae

    KW - health care access

    KW - health promotion

    KW - hepatitis A

    KW - human

    KW - immunization

    KW - Indigenous Australian

    KW - infection prevention

    KW - influenza

    KW - otitis media

    KW - pneumococcal infection

    KW - pneumonia

    KW - register

    KW - Review

    KW - Rotavirus

    KW - uterine cervix cancer

    KW - vaccination

    KW - adolescent

    KW - Australia

    KW - bacterial capsule

    KW - child welfare

    KW - female

    KW - indigenous health care

    KW - infection control

    KW - male

    KW - needs assessment

    KW - organization and management

    KW - preschool child

    KW - preventive health service

    KW - procedures

    KW - risk assessment

    KW - standards

    KW - statistics and numerical data

    KW - trends

    KW - Adolescent

    KW - Bacterial Capsules

    KW - Child

    KW - Child Welfare

    KW - Child, Preschool

    KW - Communicable Disease Control

    KW - Female

    KW - Haemophilus Vaccines

    KW - Health Services, Indigenous

    KW - Hepatitis A Vaccines

    KW - Humans

    KW - Immunization

    KW - Immunization Programs

    KW - Male

    KW - Needs Assessment

    KW - Pneumococcal Vaccines

    KW - Risk Assessment

    KW - Vaccination

    UR - http://www.scopus.com/inward/record.url?scp=84908226349&partnerID=8YFLogxK

    U2 - 10.1111/j.1440-1754.2011.02079.x

    DO - 10.1111/j.1440-1754.2011.02079.x

    M3 - Article

    VL - 50

    SP - E21-E25

    JO - Journal of Paediatrics and Child Health

    JF - Journal of Paediatrics and Child Health

    SN - 1034-4810

    IS - 10

    ER -